Intermolecular interactions between DNA and methamphetamine, amphetamine, ecstasy and their major metabolites.
Arthur F V F Reis, Igor L P Gonçalves, Abel F G Neto, Alberdan S Santos, Kamil Kuča, Eugenie Nepovimová, Antonio M J C Neto
Journal of biomolecular structure & dynamics September 2018 DOI: 10.1080/07391102.2017.1386592 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or computational study (molecular docking and molecular dynamics simulations) Peer reviewed |
|---|---|
| Population | Human DNA fragments (computational receptor models), interacting with amphetamine-type stimulants and their metabolites |
| Interventions | Amphetamine Methamphetamine 3 |
| Measures | Free Gibbs change of binding (ΔGbind) |
| Topics | MDMA |
| Keywords | Dna Methamphetamine Molecular simulations |
| Key points | The authors report that MDMA and its metabolite DHMA bind preferentially to the minor groove of human DNA, with DHMA showing more spontaneous binding (ΔGbind = -13.15 kcal/mol) than MDMA (ΔGbind = -8.61 kcal/mol). They suggest these molecules have a greater probability of causing damage to human DNA fragments, based on simulation calculations rather than experimental evidence. |
Abstract
In this work, we carried out a theoretical investigation regarding amphetamine-type stimulants, which can cause central nervous system degeneration, interacting with human DNA. These include amphetamine, methamphetamine, 3,4-Methylenedioxymethamphetamine (also known as ecstasy), as well as their main metabolites. The studies were performed through molecular docking and molecular dynamics simulations, where molecular interactions of the receptor-ligand systems, along with their physical-chemical energies, were reported. Our results show that 3,4-Methylenedioxymethamphetamine and 3,4-Dihydroxymethamphetamine (ecstasy) present considerable reactivity with the receptor (DNA), suggesting that these molecules may cause damage due to human-DNA. These results were indicated by free Gibbs change of bind (ΔGbind) values referring to intermolecular interactions between the drugs and the minor grooves of DNA, which were predominant for all simulations. In addition, it was observed that 3,4-Dihydroxymethamphetamine (ΔGbind = -13.15 kcal/mol) presented greater spontaneity in establishing interactions with DNA in comparison to 3,4-Methylenedioxymethamphetamine (ΔGbind = -8.61 kcal/mol). Thus, according with the calculations performed our results suggest that the 3,4-Methylenedioxymethamphetamine and 3,4-Dihydroxymethamphetamine have greater probability to provide damage to human DNA fragments.
Comparable studies
Other theoretical and historical papers on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens | 1986 | Theoretical or philosophical paper | |
| The Background and Chemistry of MDMA | 1986 | Historical analysis | |
| The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents* Original documents in Merck's historical archive in Darmstadt, Germany, years 1900–1960 | 2006 | Historical analysis | |
| Distinct neural mechanisms for the prosocial and rewarding properties of MDMA | 2019 | Theoretical or philosophical paper | |
| How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale | 2009 | Theoretical or philosophical paper |
Citations in the library
Cites 5
- Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats British Journal of Pharmacology October 12, 2013
- Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans British Journal of Clinical Pharmacology February 1, 2000
- Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences. Journal of Pharmacology and Experimental Therapeutics July 2011
- Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice. ACS Chemical Neuroscience February 23, 2010
- Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs. Biochemical Pharmacology June 15, 2000